This website uses cookies to store information on your computer. Some of these cookies are used for visitor analysis, others are essential to making our site function properly and improve the user experience. By using this site, you consent to the placement of these cookies. Click Accept to consent and dismiss this message or Deny to leave this website. Read our Privacy Statement for more.
Print Page   |   Contact Us   |   Sign In   |   Register
Community Search
CMC Strategy Forum January 2019
Share |

Continuous Manufacturing for Biologics 

Forum Co-chairs:
     Joslyn Brunelle, CDER, FDA
     Andrew Chang,
Novo Nordisk Inc.
   
 Manon Dubé, Health Canada
     
Rick Lu, AstraZeneca 

Scientific Organizing Committee: 
     T.G. Venkateshwaran, Merck & Co., Inc. 


The Development of Patient-focused Commercial Specifications through Understanding of Clinical Relevance and Criticality of Quality Attributes 

Forum Co-chairs:
     Maria Teresa Gutierrez-Lugo, CDER, FDA
     Anthony Mire-Sluis, AstraZeneca
     Jason Starkey, Pfizer, Inc.    

Scientific Organizing Committee: 
     Fiona Cornel, Health Canada
     JR Dobbins, Eli Lilly and Company 
     
William Egan, GSK Vaccines 
     Neha Frantz, Biogen
     Taro Fujimori, AbbVie Bioresearch Center, Inc. 
 
   Kavita Mistry, Genentech, a Member of the Roche Group



 To visit the WCBP 2019 meeting homepage, click here


 Want more information? Check out the "More in this Section" dropdown box at the top of the page!
Or contact CASSS at 510-428-0740 or info@casss.org

 


To register for this meeting, click here

To visit the CMC Strategy Forum meeting homepage, click here

To register for this meeting, click here

To visit the CMC Strategy Forum meeting homepage, click here

 
more Calendar

12/3/2018 » 12/4/2018
CMC Strategy Forum Japan 2018

Membership Software Powered by YourMembership  ::  Legal